Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

NGM/BIOWKS stock hub

NGM/BIOWKS has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NGM/BIOWKSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

314M

Nordic Growth Market

Market data

Price

Recent price action with selectable time range.

NGM/BIOWKSNGM/BIOWKS

—

Loading chart…

In the news

Latest news · NGM/BIOWKS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-32.5

P25 n/aP50 n/aP75 n/a

ROIC-24.1

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NGM/BIOWKS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

171

Groups with data

Currency

SEK

Showing 171 of 171 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Sweden
Country code	SE
Employees	26.4
Employees Change	-3.6%
Employees Change Percent	-12
Enterprise value	SEK 279.1M
Exchange	Nordic Growth Market
Financial currency	SEK
First seen	2026-05-10
Industry	Medical Instruments & Supplies
Isin	SE0007387089
Last refreshed	2026-05-10
Market cap	SEK 314M
Price	SEK 3.14
Price currency	SEK
Rev Per Employee	2,016,193.55x
Sector	Healthcare
Sic	2833
Symbol	ngm/BIOWKS
Website	https://www.bio-works.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-4.86%
EV Earnings	-18.31x
EV/FCF	-14.53x
EV/Sales	4.47x
FCF yield	-6.12%
P/B ratio	6.38x
P/S ratio	5.02x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-28.99%
EBITDA Margin	-28.17%
Gross margin	76.48%
Gross Profit	SEK 47.8M
Gross Profit Growth	90.92%
Gross Profit Growth Q	208.34%
Gross Profit Growth3 Y	18.33%
Gross Profit Growth5 Y	62.52%
Net Income	SEK -15.2M
Pretax Margin	-27.46%
Profit Margin	-24.39%
Profit Per Employee	SEK -491,839
ROA	-18.37
Roa5y	-28.68
ROCE	-36.82
ROE	-32.51
Roe5y	-57.46
ROIC	-24.15

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	139.84%
Cagr3y	-42.12%
Cagr5y	-30.6%
Revenue Growth	105.02x
Revenue Growth Q	209.69x
Revenue Growth3 Y	14.79x
Revenue Growth5 Y	53.92x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	SEK 1.01
Assets	SEK 70.8M
Cash	SEK 34.9M
Current Assets	SEK 69M
Current Liabilities	SEK 21.5M
Equity	SEK 49.2M
Interest Coverage	-18,118
Liabilities	SEK 21.6M
Long Term Assets	SEK 1.7M
Long Term Liabilities	SEK 1,000
Net Cash	SEK 34.9M
Net Cash By Market Cap	SEK 11.12
Net Cash Growth	1.9%
Net Debt Equity	SEK -0.71
Tangible Book Value	SEK 49.2M
Tangible Book Value Per Share	SEK 0.5
WACC	7.09

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.2
Inventory Turnover	1.14
Net Working Capital	SEK 12.6M
Quick ratio	2.41
Working Capital	SEK 47.5M
Working Capital Turnover	SEK 1.38

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-65.69%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	139.7%
200-day SMA	2.77
3Y total return	-80.62%
50-day SMA	3.2
50-day SMA vs 200-day SMA	50over200
5Y total return	-83.9%
All Time High	28.7
All Time High Change	-89.06%
All Time High Date	2021-12-01
All Time Low	0.72
All Time Low Change	335.93%
All Time Low Date	2024-12-19
ATR	0.23
Beta	0.52
Beta1y	-0.68
Beta2y	0.28
Ch YTD	19.85
High	3.29
High52	3.98
High52 Date	2026-03-31
High52ch	-21.11%
Low	3.1
Low52	1.15
Low52 Date	2025-05-12
Low52ch	173.04%
Ma50ch	-1.97%
Price vs 200-day SMA	13.36%
RSI	45.52
RSI Monthly	44.58
RSI Weekly	54.37
Sharpe ratio	1.54x
Sortino ratio	2.89
Total Return	-65.69%
Tr YTD	19.85
Tr1m	-10.29%
Tr1w	1.62%
Tr3m	14.6%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	SEK -18.1M
Operating margin	-28.99

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	44,841,765%
Shares Insiders	27.97%
Shares Institutions	8.57%
Shares Out	100,010,822
Shares Qo Q	31.71%
Shares Yo Y	65.69%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	SEK -19.2M
Average Volume	59,333.5x
Bv Per Share	0.5
CAPEX	SEK -404,000
Ch1m	-10.29
Ch1w	1.62
Ch1y	139.7
Ch3m	14.6
Ch3y	-80.62
Ch5y	-83.9
Ch6m	14.18
Change	-0.63%
Change From Open	-0.63
Close	3.16
Days Gap	0
Depreciation Amortization	512,000
Dollar Volume	272,391.9
Earnings Date	2026-05-13
EBIT	SEK -18.1M
EBITDA	SEK -17.6M
EPS	SEK -0.18
F Score	1
FCF	SEK -19.2M
FCF EV Yield	-6.88x
FCF Per Share	SEK -0.19
Financing CF	20,082,000
Fiscal Year End	December
Founded	2,006
Income Tax	SEK -1.9M
Investing CF	-404,000
Is Primary Listing	1
Last Earnings Date	2026-02-20
Last Report Date	2025-12-31
Ma150	2.81
Ma150ch	11.78%
Ma20	3.23
Ma20ch	-2.85%
Net CF	653,000
Next Earnings Date	2026-05-13
Open	3.16
Position In Range	21.05
Ppne	1,710,000
Price Date	2026-05-08
Ptbv Ratio	6.38
Relative Volume	1.46x
Revenue	62,502,000x
Tax By Revenue	-3.07x
Tr6m	14.18%
Volume	86,749
Z Score	-1.75

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NGM/BIOWKS pay a dividend?

Capital-return profile for this ticker.

Performance

NGM/BIOWKS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NGM/BIOWKS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+8.6%

Share of float held by funds and institutions

Insider ownership

+28.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+65.7%

Negative means the company is buying back shares.

Technical

NGM/BIOWKS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

45.5

Neutral momentum band

Price vs 200-day MA

+13.4%

50/200-day relationship not available

Beta (5Y)

0.52

Less volatile than the market

Sharpe ratio

1.54

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NGM/BIOWKS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ngm/BIOWKS stock rating?

ngm/BIOWKS is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ngm/BIOWKS analysis?

The full report lives at /stocks/ngm/BIOWKS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ngm/BIOWKS?

The latest report frames ngm/BIOWKS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ngm/BIOWKS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.